Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / How Emergency Room Chains Got Rolled Up by PE
Transcript
- Lucas: There's a strip mall in Midland, Texas where a sign reads '24-Hour Emergency Room' in bright blue letters, and it sits right between a mattress store and a vape shop. Luna: That's a freestanding ER — not attached to a hospital, just out there on its own. Lucas: Exactly. And twenty years ago there were maybe a hundred of these in the entire country. Now there are well over seven hundred, and private equity has quietly backed many of the biggest chains. Luna: So this is another roll-up story, but in emergency medicine. That feels... different. Lucas: It is different, because the economics are weird. A freestanding ER charges hospital-level facility fees — we're talking anywhere from one thousand to three thousand dollars just to walk in the door — but they don't have the overhead of a full trauma center. And that gap is exactly what attracted PE. Luna: Let's talk about a specific chain. Which one? Lucas: One of the biggest is a company called Adeptus Health, which started in Texas around 2002. By 2015, they had fifty-something locations across several states. They went public, then got taken private by a PE firm, then filed for bankruptcy in 2017. Luna: That arc — rapid expansion, public exit, PE buyout, bankruptcy — that's almost a template. Lucas: It is. And the reason it blew up is instructive. Adeptus relied heavily on a single insurer contract that paid very well. When that contract got renegotiated downward, their margins collapsed. They had taken on debt to build all those new locations, and suddenly they couldn't cover the interest. Luna: So the roll-up itself wasn't the problem — it was the customer concentration. Lucas: Right. And that's a pattern across healthcare roll-ups. The underlying business looks stable until a payer changes the rules. Luna: Speaking of rules — the No Surprises Act went into effect in 2022. That law was designed to protect patients from exactly the kind of bills these freestanding ERs were famous for generating. Lucas: That's the key tension. Freestanding ERs often operate in affluent suburbs where patients have good insurance, but they also attract people who don't realize it's not a regular urgent care. You walk in with a stomach ache, they run a CT scan and some blood work, and you get a fifteen hundred dollar bill for the 'emergency' visit. Luna: And private equity owners are aware of this. Some chains have been sued for deceptive marketing — putting up signs that say 'Emergency' in big letters but not clearly stating the pricing. Lucas: Yeah. And the roll-up play compounds the incentive. If you own three ERs, you might think carefully about reputation. If you own sixty, the pressure to fill beds — or rather, to get butts on gurneys — can override local norms. Luna: But not every pe backed ER chain has blown up. Are there any that have managed the model well? Lucas: There are a few that operate more like a hybrid — they partner with a hospital system, so they function as a satellite ER with the same pricing and protocols. That reduces the surprise-bill risk because the patient is technically within the hospital's network. Luna: So the model works if you don't try to squeeze every last dollar. Lucas: Exactly. The aggressive ones over-leverage, under-invest in compliance, and treat the ER like a high-volume retail clinic. That's where the trouble starts. Luna: And now there's regulatory momentum. Some states are requiring freestanding ERs to post prices clearly, and Medicare is looking at cutting facility fees for off-campus ERs. Lucas: Yeah, and that's the big risk for any PE firm sitting on a chain right now. If reimbursement gets cut by twenty percent, the debt service doesn't change. The math stops working very fast. Luna: It makes you wonder whether the next wave of consolidation will happen in a different part of healthcare. Something less regulated, maybe. Lucas: Before we go there — and I promise this connects — I want to mention something. If conversations like this have given you a clearer picture of how money moves through your own healthcare system, it's worth knowing that the show stays ad-free because of listener support. A couple of dollars a month at buy me a coffee dot com slash fexingo genuinely makes a difference. Luna: Yeah, it's not a huge ask. And it keeps us independent, which is the whole point. Lucas: Exactly. So back to where the next wave might hit — I think we're already seeing it in urgent care, which is even less regulated than freestanding ERs and has way higher patient volume. Luna: Urgent care has been consolidating for a while, but the PE firms I track are getting more sophisticated. They're not just buying clinics; they're buying the real estate underneath them. Lucas: Right. So the roll-up becomes a real estate play with a healthcare veneer. And if the clinic loses money, you still own the building. Luna: Exactly. That's a much harder business to break. Less sensitivity to reimbursement changes. Lucas: And that's the lesson from the ER roll-up story: the financial structure matters more than the medical model. PE firms that treat healthcare like any other retail business end up owning a headache. The ones that respect the regulatory and billing complexity can do fine. Luna: But for patients, it's a gamble. You walk into a bright blue sign between a mattress store and a vape shop, and you have no idea who owns it or what you'll owe. Lucas: And that lack of transparency is probably the biggest failure of the whole experiment. The roll-up didn't create better care or lower prices — it created a more efficient billing machine. Luna: And now regulators are catching up. The question is whether the next model will be better, or just better hidden. Lucas: That's the question every PE firm in healthcare has to answer. And the answer isn't obvious.